• Coronavirus in Hungary
  • Budapest
  • Hungary border control
  • HelloMagyar
EnglishFrenchGermanSpanish
EnglishFrenchGermanSpanish
UK funds another coronavirus vaccine programUK funds another coronavirus vaccine programUK funds another coronavirus vaccine programUK funds another coronavirus vaccine program
  • Politics
  • Business
  • Society
  • Sport
  • Culture
  • Special Hungary
  • News To Go
  • World
  • Contact Us
  • About us
  • About us
  • Contact Us
  • Privacy Policy
✕
Breaking News
Support us
Daily News Hungary Daily News Hungary · 26/08/2020
· World

UK funds another coronavirus vaccine program

coronavirus drugs/medications health United Kingdom
corona vaccine

Pexels/Polina Tankilevitch

The University of Cambridge announced on Wednesday that a newly developed SARS-CoV-2 vaccine candidate has received funding support from the British government and could start clinical trials in late autumn or early next year.

The program is a collaboration between the University of Cambridge, Cambridge spin-out company DIOSynVax, and the University Hospital Southampton NHS (National Health Service) Foundation Trust.

Innovate UK, the British government’s innovation agency, has provided the program with 1.9 million pounds (around 2.5 million U.S. dollars) in funding.

Called DIOS-CoVax2, the vaccine candidate is developed using banks of genetic sequences of all known coronaviruses, including those from bats, the natural hosts of many relatives of human coronaviruses.

The team said they have developed libraries of computer-generated antigen structures encoded by synthetic genes that can train the human immune system to target key regions of the virus and to produce beneficial anti-viral responses.

“We’re looking for chinks in its armor, crucial pieces of the virus that we can use to construct the vaccine to direct the immune response in the right direction,” said Professor Jonathan Heeney, head of the Laboratory of Viral Zoonotics at the University of Cambridge, and founder of DIOSynVax.

“Ultimately we aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses that may spill over from animals to humans,” said Heeney.

The vaccine candidate is designed to be delivered pain-free without a needle into the skin, using a simple jet of air.

And it can be freeze-dried as a powder and is therefore heat stable, meaning that it does not need to be cold-stored. This makes transport and storage much more straightforward.

Russia to start COVID-19 vaccine output within 2 weeks
Read alsoRussia to start COVID-19 vaccine output within 2 weeks

The team said that this is particularly important in low- and middle-income countries where the infrastructure to make this possible can be costly.

coronavirus dentist
Read alsoCoronavirus – Survey shows most Hungarians would get vaccinated

Source: Xinhua

coronavirus drugs/medications health United Kingdom
Share
Daily News Hungary
Daily News Hungary

Leave a Reply

Your email address will not be published. Required fields are marked *

SUPPORT US

Subscribe to our newsletter

Sign up to receive daily updates, news & stories about Hungary!

Select your location below or enter your country so we can deliver our morning newsletters to you in time.


Thank you!

You have successfully joined our subscriber list.


.

Latest news
  • What happened today in Hungary? – 30 January, 2023
  • Boysen Group to create 400 new jobs in Hungary
  • Austrian Defence Minister Klaudia Tanner visits Hungary
  • This is why fuel in Hungary is the most expensive in the region
  • Medicine shortage can stay for a long time in Hungary
  • Hungarian tourism boomed in 2022, but where did most of the visitors come from?
  • President Novák meets Azeri counterpart Ilham Alijev in Budapest
  • Stadiums, World Championships: multiple priced prestige projects in Hungary

About us

Contact us

Copyright rules

© 2023 DailyNewsHungary. All rights reserved! | Server and development by Svigelj Levente E.V